Skip to search formSkip to main contentSkip to account menu

alifedrine

Known as: 1-Propanone, 1-cyclohexyl-3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-, (R-(R*,S*))- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Cardiotonic AgentsOxyfedrine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Relationship between the structure and effects of cardiotonics with nonglycoside and noncatecholamine structure
Congestive cardiac insufficiency (CCI) is the main cause of morbidity and mortality of the population in the industrially… 
1989
1989
Effects of the Novel β‐Adrenergic Partial Agonist Alifedrine on Cardiac Performance in Dogs with Acute Ischemic Left Ventricular Failure
Acute ischemic left ventricular failure was induced in dogs by coronary embolization with plastic microspheres, resulting in… 
1989
1989
Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with acute ischemic left ventricular failure.
Acute ischemic left ventricular failure was induced in dogs by coronary embolization with plastic microspheres, resulting in… 
1989
1989
Acute haemodynamic effects of different doses of alifedrine in congestive heart failure
SummaryThe haemodynamic effects of single oral doses of alifedrine 40 mg, 50 mg, 60 mg and placebo were compared in 30 patients… 
1988
1988
Haemodynamic effects of intravenous and oral alifedrine in patients with cardiac failure.
A randomized, double-blind, double-crossover, placebo-controlled haemodynamic study was undertaken in patients with Grade II/III… 
1988
1988
Alifedrine, a positive inotropic agent that moderately reduces the severity of ischaemia and reperfusion-induced ventricular arrhythmias.
1984
1984
[Acute hemodynamic effects of alifedrine in patients with heart failure].
The newly synthesized cardiotonic agent alifedrine (1-cyclohexyl-3-[(1S, 2R)-2-hydroxy-methyl-2-phenylethylamino]-propan-1-one… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)